Hodgkinsine B
CAS: 586955-76-2
Ref. 3D-LYA95576
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
Hodgkinsine B is a potent inhibitor of the kinase activity of nintedanib, a drug used to treat cancer. It was originally isolated from Chinese urine and has shown promising results in inhibiting the growth of cancer cells. Hodgkinsine B has been shown to induce apoptosis, or programmed cell death, in human tumor cells by disrupting the signaling pathways that promote cell survival. This compound also exhibits analogs of glimepiride, which is used to treat diabetes. Additionally, Hodgkinsine B has been found to have potential therapeutic applications as an inhibitor for apomorphine-induced dyskinesia and as an anti-inflammatory agent due to its ability to inhibit vanillin-induced edema. Overall, Hodgkinsine B shows great promise as a potential treatment for cancer and other diseases.
Propiedades químicas
Consulta técnica sobre: 3D-LYA95576 Hodgkinsine B
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
